Cargando…
Dengue vaccine acceptability before and after the availability of COVID-19 vaccines in Puerto Rico
Dengue is a growing public health threat, causing approximately 400 million infections annually. In June 2021, the Advisory Committee on Immunization Practices recommended the first dengue vaccine (CYD-TDV) for children aged 9–16 years with a previous dengue infection, living in endemic areas, such...
Autores principales: | Rodriguez, Dania M., Major, Chelsea G., Sánchez-González, Liliana, Jones, Emma, Delorey, Mark J., Alonso, Claudia, Rivera-Amill, Vanessa, Paz-Bailey, Gabriela, Adams, Laura E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160531/ https://www.ncbi.nlm.nih.gov/pubmed/37173267 http://dx.doi.org/10.1016/j.vaccine.2023.04.081 |
Ejemplares similares
-
COVID-19 Vaccination Intention in a Community Cohort in Ponce, Puerto Rico
por: Sánchez-González, Liliana, et al.
Publicado: (2022) -
Arbovirus risk perception as a predictor of mosquito-bite preventive behaviors in Ponce, Puerto Rico
por: Dussault, Josée M., et al.
Publicado: (2022) -
Risk factors for infection with chikungunya and Zika viruses in southern Puerto Rico: A community-based cross-sectional seroprevalence survey
por: Adams, Laura E., et al.
Publicado: (2022) -
Cost-effectiveness of dengue vaccination in Puerto Rico
por: España, Guido, et al.
Publicado: (2021) -
Economic Cost of Dengue in Puerto Rico
por: Halasa, Yara A., et al.
Publicado: (2012)